Scotiabank lowered the firm’s price target on Andlauer Healthcare (ANDHF) to C$43 from C$44.50 and keeps a Sector Perform rating on the shares.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANDHF:
- Andlauer Healthcare Group Declares First Quarter Dividend
- Andlauer Healthcare Group Forms Joint Venture with NowPac
- Andlauer Healthcare price target raised to C$44.50 from C$44 at Scotiabank
- Andlauer Healthcare price target lowered to C$53 from C$54 at TD Securities
- Andlauer Healthcare Group Reports Stable 2024 Earnings